Chloroquine blocks a mutant Kir2.1 channel responsible for short QT syndrome and normalizes repolarization properties in silico
- PMID: 19710529
- PMCID: PMC3711575
- DOI: 10.1159/000233241
Chloroquine blocks a mutant Kir2.1 channel responsible for short QT syndrome and normalizes repolarization properties in silico
Abstract
Short QT Syndrome (SQTS) is a novel clinical entity characterized by markedly rapid cardiac repolarization and lethal arrhythmias. A mutation in the Kir2.1 inward rectifier K+ channel (D172N) causes one form of SQTS (SQT3). Pharmacologic block of Kir2.1 channels may hold promise as potential therapy for SQT3. We recently reported that the anti-malarial drug chloroquine blocks Kir2.1 channels by plugging the cytoplasmic pore domain. In this study, we tested whether chloroquine blocks D172N Kir2.1 channels in a heterologous expression system and if chloroquine normalizes repolarization properties using a mathematical model of a human ventricular myocyte. Chloroquine caused a dose- and voltage-dependent reduction in wild-type (WT), D172N and WT-D172N heteromeric Kir2.1 current. The potency and kinetics of chloroquine block of D172N and WT-D172N Kir2.1 current were similar to WT. In silico modeling of the heterozygous WT-D172N Kir2.1 condition predicted that 3 microM chloroquine normalized inward rectifier K+ current magnitude, action potential duration and effective refractory period. Our results suggest that therapeutic concentrations of chloroquine might lengthen cardiac repolarization in SQT3.
Copyright (c) 2009 S. Karger AG, Basel.
Figures






References
-
- Harris L, Downar E, Shaikh NA, Chen T. Antiarrhythmic potential of chloroquine: New use for an old drug. Can J Cardiol. 1988;4:295–300. - PubMed
-
- Sanchez-Chapula JA, Salinas-Stefanon E, Torres-Jacome J, Benavides-Haro DE, Navarro-Polanco RA. Blockade of currents by the antimalarial drug chloroquine in feline ventricular myocytes. J Pharmacol Exp Ther. 2001;297:437–445. - PubMed
-
- Benavides-Haro DE, Sanchez-Chapula JA. Chloroquine blocks the background potassium current in guinea pig atrial myocytes. Naunyn Schmiedebergs Arch Pharmacol. 2000;361:311–318. - PubMed
-
- Bustos M, Gay F, Diquet B, Thomare P, Warot D. The pharmacokinetics and electrocardiographic effects of chloroquine in healthy subjects. Trop Med Parasitol. 1994;45:83–86. - PubMed
-
- Sowunmi A, Salako LA, Walker O, Ogundahunsi OA. Clinical efficacy of mefloquine in children suffering from chloroquine-resistant plasmodium falciparum malaria in nigeria. Trans R Soc Trop Med Hyg. 1990;84:761–764. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources